0001651281-15-000002.txt : 20150819
0001651281-15-000002.hdr.sgml : 20150819
20150819140741
ACCESSION NUMBER: 0001651281-15-000002
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150817
FILED AS OF DATE: 20150819
DATE AS OF CHANGE: 20150819
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACUCELA INC.
CENTRAL INDEX KEY: 0001400482
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 020592619
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 SECOND AVE.
STREET 2: SUITE 4200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 206-805-8300
MAIL ADDRESS:
STREET 1: 1301 SECOND AVE.
STREET 2: SUITE 4200
CITY: SEATTLE
STATE: WA
ZIP: 98101
FORMER COMPANY:
FORMER CONFORMED NAME: Acucela Inc
DATE OF NAME CHANGE: 20070523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHEIBLER LUKAS
CENTRAL INDEX KEY: 0001651281
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55133
FILM NUMBER: 151063659
MAIL ADDRESS:
STREET 1: 1301 SECOND AVENUE, SUITE 4200
CITY: SEATTLE
STATE: WA
ZIP: 98101
3
1
wf-form3_144000765162895.xml
FORM 3
X0206
3
2015-08-17
0
0001400482
ACUCELA INC.
M??????
0001651281
SCHEIBLER LUKAS
C/O ACUCELA INC.
1301 SECOND AVE., SUITE 4200
SEATTLE
WA
98101
0
1
0
0
EVP of Translational Medicine
Common Stock
0
D
The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192000).
No securities beneficially held.
/s/ John E. Gebhart as attorney-in-fact for Lukas Scheibler
2015-08-19